Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A call to action for the new decade of vaccines.
Moxon, ER; Das, P; GREENWOOD, B; HEYMANN, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G;
2011
Lancet, (2011).378 9788 10.1016/S0140-6736(11)60766-6.
Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.
Urueña, A; Pippo, T; Betelu, MS; Virgilio, F; Giglio, N; Gentile, A; Jimenez, SG; Jáuregui, B; CLARK, AD; Diosque, M; Vizzotti, C;
2011
Vaccine, (2011).29 31 10.1016/j.vaccine.2011.04.111.
Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
Barreto, ML; Pereira, SM; PILGER, D; Cruz, AA; Cunha, SS; Sant'Anna, C; Ichihara, MY; Genser, B; RODRIGUES, LC;
2011
Vaccine, (2011).29 31 10.1016/j.vaccine.2011.05.023.
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.
Postma, MJ; JIT, M; Rozenbaum, MH; Standaert, B; Tu, H-A; Hutubessy, RC W;
2011
BMC medicine, (2011).9 1 10.1186/1741-7015-9-84.
National decision-making on adopting new vaccines: a systematic review.
BURCHETT, HE D; MOUNIER-JACK, S; GRIFFITHS, UK; MILLS, AJ;
2011
Health policy and planning, (2011).27 Sup suppl 10.1093/heapol/czr049.
Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.
Fowlkes, A; Witte, D; Beeler, J; Audet, S; Garcia, P; Curns, A; Yang, C; Fudzulani, R; Broadhead, R; Bellini, WJ; CUTTS, F; Helfand, RF;
2011
The Journal of infectious diseases, (2011).204 Su suppl_ 10.1093/infdis/jir135.
The future of immunisation policy, implementation, and financing.
Levine, OS; Bloom, DE; Cherian, T; De Quadros, C; Sow, S; Wecker, J; Duclos, P; GREENWOOD, B;
2011
Lancet, (2011).378 9789 10.1016/S0140-6736(11)60406-6.
Impact of measles elimination activities on immunization services and health systems: findings from six countries.
HANVORAVONGCHAI, P; MOUNIER-JACK, S; Oliveira Cruz, V; BALABANOVA, D; Biellik, R; Kitaw, Y; Koehlmoos, T; Loureiro, S; Molla, M; Nguyen, H; Ongolo-Zogo, P; Sadykova, U; Sarma, H; Teixeira, M; Uddin, J; Dabbagh, A; GRIFFITHS, UK;
2011
The Journal of infectious diseases, (2011).204 Su suppl_ 10.1093/infdis/jir091.
How can measles eradication strengthen health care systems?.
GRIFFITHS, UK; MOUNIER-JACK, S; OLIVEIRA-CRUZ, V; BALABANOVA, D; HANVORAVONGCHAI, P; Ongolo, P;
2011
The Journal of infectious diseases, (2011).204 Su suppl_ 10.1093/infdis/jir090.
Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Bejon, P; COOK, J; Bergmann-Leitner, E; Olotu, A; Lusingu, J; Mwacharo, J; Vekemans, J; Njuguna, P; Leach, A; Lievens, M; Dutta, S; Von Seidlein, L; Savarese, B; Villafana, T; Lemnge, MM; Cohen, J; Marsh, K; CORRAN, PH; Angov, E; RILEY, EM; DRAKELEY, CJ;
2011
The Journal of infectious diseases, (2011).204 1 10.1093/infdis/jir222.